JA Stone
Impact in
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment
-
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 3
- Pharmacogenetics and Drug Metabolism 1
-
- Antifungal resistance and susceptibility 1
- Co-authors
- Robert A. Wise (3 shared papers)Jenny M. Andrews (3 shared papers)Tomoko Freshwater (2 shared papers)Jeroen Elassaiss‐Schaap (2 shared papers)Malidi Ahamadi (2 shared papers)Rik de Greef (2 shared papers)James T. Kost (2 shared papers)Marian Iwamoto (2 shared papers)
- Journals
- European Journal of Clinical Microbiology & Infectious Diseases (2 papers)Clinical Pharmacology & Therapeutics (2 papers)CPT Pharmacometrics & Systems Pharmacology (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
JA Stone
13 papers receiving 590 citations
Peers
Comparison fields: 5 of 53
- Infectious Diseases 201
- Oncology 156
- Pharmacology 63
- Pharmacology 77
- Applied Microbiology and Biotechnology 12
Countries citing papers authored by JA Stone
This map shows the geographic impact of JA Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JA Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JA Stone more than expected).
Fields of papers citing papers by JA Stone
This network shows the impact of papers produced by JA Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JA Stone. The network helps show where JA Stone may publish in the future.
Co-authors
The 25 scholars most cited alongside JA Stone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 145 | |
| 2 | 2016 | 129 | |
| 3 | 2009 | 81 | |
| 4 | 2016 | 72 | |
| 5 | 1988 | 54 | |
| 6 | 1988 | 42 | |
| 7 | 1989 | 33 | |
| 8 | 1986 | 26 | |
| 9 | 1986 | 18 | |
| 10 | Drug interactions between caspofungin and tacrolimus | 2001 | 18 |
| 11 | 1989 | 8 | |
| 12 | 1990 | 7 | |
| 13 | 1988 | 3 |
About JA Stone
JA Stone is a scholar working on Pharmacology, Infectious Diseases, Oncology, Modeling and Simulation and Pharmacology, having authored 13 papers that have together received 636 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Antifungal resistance and susceptibility (1 paper), Pharmacogenetics and Drug Metabolism (1 paper), Helicobacter pylori-related gastroenterology studies (1 paper), Mathematical Biology Tumor Growth (1 paper) and Gut microbiota and health (1 paper). The work is most often cited by research in Infectious Diseases (201 citations), Oncology (156 citations), Pharmacology (63 citations), Pharmacology (77 citations) and Applied Microbiology and Biotechnology (12 citations). JA Stone has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Robert A. Wise, Jenny M. Andrews, Tomoko Freshwater, Jeroen Elassaiss‐Schaap, Malidi Ahamadi, Rik de Greef, James T. Kost, Marian Iwamoto, Amelia S. Petry and John A. Wagner. Their work appears in journals such as European Journal of Clinical Microbiology & Infectious Diseases, Clinical Pharmacology & Therapeutics, CPT Pharmacometrics & Systems Pharmacology, Journal of Antimicrobial Chemotherapy and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.